Showing 20 of 33 recruiting trials for “takayasu-arteritis”
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
👨⚕️ Sebastian H Unizony, M.D., Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases📍 7 sites📅 Started Dec 2025View details ↗
RecruitingNCT07084480 ↗
Giant Cell Arteritis - Ways to Precision Medicine
RecruitingNCT07351422 ↗
Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
RecruitingNCT07276087 ↗
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
RecruitingNCT06894602 ↗
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
RecruitingNCT05749094 ↗
Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
👨⚕️ Jean-Paul Makhzoum, MD, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, University of Montreal📍 6 sites📅 Started Aug 2025View details ↗
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
RecruitingNCT06742671 ↗
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
👨⚕️ Christophe RONCATO, MD, Groupe Hospitalier de la Rochelle Ré Aunis📍 1 site📅 Started Feb 2025View details ↗
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
👨⚕️ Britta Maurer, Department of Rheumatology and Immunology, Inselspital, University of Bern, Bern, Switzerland📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06609668 ↗
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
RecruitingNCT06271018 ↗
TocILizumab in aorTitis in GCA (TILT)
🏥 Groupe français d'étude des Maladies Inflammatoires de loeil📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06279065 ↗
Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis
RecruitingNCT05854927 ↗
Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)
Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)
👨⚕️ Yi Zhao, MD, Xuanwu Hospital, Capital Medical University, China, 10053📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06004154 ↗
Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)
RecruitingNCT05935709 ↗
DANIsh VASculitis Database (DANIVAS)
👨⚕️ Berit Dalsgaard Nielsen, Ass prof, Led og Bindevæv, Aarhus University Hospital, Palle Juul-Jensens Boulevard 59, 8200 Aarhus N, DK📍 2 sites📅 Started Nov 2023View details ↗
RecruitingNCT06460142 ↗
Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
👨⚕️ Valentin S. Schäfer, Univ. Prof., Department of Rheumatology and Clinical Immunology, University Hospital Bonn📍 1 site📅 Started Sep 2023View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →